Alexion Pharma (ALXN) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.11, $0.02 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $701 million versus the consensus estimate of $710.98 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Alibaba ADR climbs on analyst upgrades, AI momentum
- UBS Reiterates Buy Rating on Pepsico (PEP) on Q3 Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
